High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk

TUESDAY, Aug. 11, 2026-- High-dose eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) treatment is associated with increased atrial fibrillation (AF) risk in patients at high cardiovascular disease risk, according to a study published online...